Illumina Inc. Announces that U.S. Federal Court Issues Preliminary Injunction Against BGI Companies
Illumina, Inc. (NASDAQ: ILMN) today announced that the U.S. District Court for the Northern District of California issued a preliminary injunction order against several BGI companies, including MGI Tech Co., Ltd., Complete Genomics Inc., BGI Americas Corp., and MGI Americas Inc.
- Illumina, Inc. (NASDAQ: ILMN) today announced that the U.S. District Court for the Northern District of California issued a preliminary injunction order against several BGI companies, including MGI Tech Co., Ltd., Complete Genomics Inc., BGI Americas Corp., and MGI Americas Inc.
- The preliminary injunction was granted in two patent infringement lawsuits that Illumina filed against BGI in June 2019 (Case No.
- The preliminary injunction order prohibits BGI from launching its sequencing instruments and related reagents in the United States.
- It validates that BGI has blatantly copied Illuminas proprietary sequencing chemistry, said Charles Dadswell, SVP and General Counsel for Illumina.